We are live on
!
Find out more
BCB
Brian C. Broderick Portfolio holdings
AUM
$542M
1-Year Est. Return
20.28%
This Fund
S&P 500
This Quarter
Est. Return
+1.8%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$203M
AUM Growth
+$2.55M
(+1.3%)
Cap. Flow
+$933K
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
33.71%
Holding
98
New
7
Increased
25
Reduced
34
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$407K |
| 2 |
COL
Rockwell Collins
COL
|
+$204K |
| 3 |
RTX Corp
RTX
|
+$204K |
| 4 |
Black Hills Corp
BKH
|
+$192K |
| 5 |
Oracle
ORCL
|
+$175K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EPZM
Epizyme, Inc
EPZM
|
+$758K |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$361K |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$303K |
| 4 |
Johnson & Johnson
JNJ
|
+$233K |
| 5 |
Royal Bank of Canada
RY
|
+$202K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.43% |
| 2 | Industrials | 18.27% |
| 3 | Technology | 18.23% |
| 4 | Energy | 14.92% |
| 5 | Consumer Staples | 7.26% |
Similar funds
MAM
GPWA
WCA
ISB
CIAM
FMC
HCM
FSA
Brian C. Broderick's Q1 2014 Portfolio in Review
As of Q1 2014, Brian C. Broderick held 98 positions worth $203M, up 1.3% from $201M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Brian C. Broderick's Q1 2014 filing shows 7 new, 25 increased, 34 reduced and 4 closed positions. Its largest new stake was Rockwell Collins: 2,594 shares worth $207K. The largest sale was Epizyme, Inc, an estimated $758K.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.
- Brian C. Broderick's largest Q1 2014 buy was Rockwell Collins: 2,594 shares worth $207K.
- Brian C. Broderick added most to Qualcomm in Q1 2014, an estimated $407K increase.
- Brian C. Broderick's biggest Q1 2014 reduction was Epizyme, Inc, cutting an estimated $758K.
- Brian C. Broderick fully exited Teva Pharmaceuticals in Q1 2014, selling an estimated $303K.
- Brian C. Broderick's ten largest holdings make up 34% of its $203M portfolio in Q1 2014.
- Brian C. Broderick opened 7 new positions and closed 4 in Q1 2014.
- Brian C. Broderick's portfolio value rose 1.3% quarter-over-quarter to $203M.
Based on Brian C. Broderick's 13F filing for Q1 2014, filed 29 May 2014.